Morning Headlines 6/26/25
$40 Million to Obliterate Specialty Drug Paperwork
Mandolin, which uses AI agents to manage specialty drug intake, benefits, prior authorizations, and RCM, raises $40 million in seed and Series A funding.
Best Buy Sells Current Health Back To Co-Founder, Former CEO
Best Buy divests care-at-home technology company Current Health less than four years after acquiring it for $400 million, selling it back to co-founder and former CEO Christopher McGhee.
Health IT vendor BlueBriX announces $15 million in new funding.
Veradigm Provides 2025 Financial & Business Update
Veradigm expects to bring its SEC filings up to date sometime next year, after which it will seek to relist its stock.
https://www.youtube.com/watch?v=b0l3QWUXVho